In the article, the authors discuss the local treatment of atopic eczema. They give data from the series of clinical studies on the application of non steroid medication in the children — calcineurin blocker pimecrolimus. This group is specifically essential in the event of the sensitive skin areas injury, where the skin absorptive capability and side effects development probability are the highest during the long term application of the topic glucocorticosteroids. The authors present to colleagues the first results of their experience in treatment of the children with atopic eczema.Key words: atopic eczema, treatment, calcineurin blockers, pimecrolimus, children
<em>Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus ...
The article discusses key aspects of the pathogenesis of atopic dermatitis and issues of the selecti...
Due to high prevalence in the pediatric population, chronic recurrent course and difficulties in cho...
In the article, the authors discuss the local treatment of atopic eczema. They give data from the se...
The article highlights the findings of the open surveying uncontrolled multicentric postmarketing re...
The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fa...
Jonathan M SpergelDivision of Allergy and Immunology, The Children&rsquo;s Hospital of Philadelp...
Two new topical immunomodulators, pimecrolimus cream and tacrolimus ointment for atopic dermatitis (...
Two new topical immunomodulators, pimecrolimus cream and tacrolimus ointment for atopic dermatitis (...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Increasing effectiveness of topical exposure in atopic dermatitis in children, as well as search for...
<p><em>Atopic dermatitis is a chronic allergic inflammation of skin. Topical corticosteroids, calcin...
Background: Atopic eczema is a common skin condition. It has the potential to severely impair qualit...
The object of the investigation was to estimate the basic therapy of atopic dermatitis (ad) in child...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
<em>Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus ...
The article discusses key aspects of the pathogenesis of atopic dermatitis and issues of the selecti...
Due to high prevalence in the pediatric population, chronic recurrent course and difficulties in cho...
In the article, the authors discuss the local treatment of atopic eczema. They give data from the se...
The article highlights the findings of the open surveying uncontrolled multicentric postmarketing re...
The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fa...
Jonathan M SpergelDivision of Allergy and Immunology, The Children&rsquo;s Hospital of Philadelp...
Two new topical immunomodulators, pimecrolimus cream and tacrolimus ointment for atopic dermatitis (...
Two new topical immunomodulators, pimecrolimus cream and tacrolimus ointment for atopic dermatitis (...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Increasing effectiveness of topical exposure in atopic dermatitis in children, as well as search for...
<p><em>Atopic dermatitis is a chronic allergic inflammation of skin. Topical corticosteroids, calcin...
Background: Atopic eczema is a common skin condition. It has the potential to severely impair qualit...
The object of the investigation was to estimate the basic therapy of atopic dermatitis (ad) in child...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
<em>Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus ...
The article discusses key aspects of the pathogenesis of atopic dermatitis and issues of the selecti...
Due to high prevalence in the pediatric population, chronic recurrent course and difficulties in cho...